Idioma:

Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions

Magdalinou, Nadia ; Lees, Andrew J ; Zetterberg, Henrik

Journal of neurology, neurosurgery and psychiatry, 2014-10, Vol.85 (10), p.1065-1075 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por

Título:
Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions
Autor: Magdalinou, Nadia ; Lees, Andrew J ; Zetterberg, Henrik
Assuntos: Biomarkers - cerebrospinal fluid ; Early Diagnosis ; Humans ; Nerve Tissue Proteins - cerebrospinal fluid ; Neurodegeneration ; Neurosciences ; Neurovetenskaper ; Parkinsonian Disorders - cerebrospinal fluid ; Parkinsonian Disorders - diagnosis
É parte de: Journal of neurology, neurosurgery and psychiatry, 2014-10, Vol.85 (10), p.1065-1075
Notas: ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ObjectType-Article-1
ObjectType-Feature-2
Descrição: Parkinsonian diseases comprise a heterogeneous group of neurodegenerative disorders, which show significant clinical and pathological overlap. Accurate diagnosis still largely relies on clinical acumen; pathological diagnosis remains the gold standard. There is an urgent need for biomarkers to diagnose parkinsonian disorders, particularly in the early stages when diagnosis is most difficult. In this review, several of the most promising cerebrospinal fluid candidate markers will be discussed. Their strengths and limitations will be considered together with future developments in the field.
Editor: England: BMJ Publishing Group
Idioma: Inglês

Links

Voltar para lista de resultados